Stay updated on SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial
Sign up to get notified when there's something new on the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page.

Latest updates to the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; deletions remove a funding-status notice and the prior Revision: v3.4.1, reflecting routine site maintenance rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedNotice about a lapse in government funding has been added to the top of the page and the revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedThese are minor UI and release notes edits (adding 'Show glossary', updating QC criteria labeling to 'Last Update Submitted that Met QC Criteria', standardizing 'No FEAR Act' wording, and updating the revision to v3.4.0) that do not affect the study content, eligibility, outcomes, or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded revision label 'Revision: v3.3.4' and removed the previous label 'Revision: v3.3.3'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new Locations section is added and shows Shandong as a study site, replacing the previous Shandong Locations entry. The HHS Vulnerability Disclosure link is removed and the page revision tag is updated to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedThe update is a minor revision label change (added Revision: v3.3.2, removed v3.2.0) and does not modify study details, eligibility criteria, outcomes, or schedule. There are no changes to the core content or purpose of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page.